DeNovo Ventures was formed in 2000 by seasoned investors and experienced medical device entrepreneurs who sought to share the lessons
Business Model:
Revenue: $16.8M
Employees: 11-50
Address: 14612 Big Basin Way
City: Saratoga
State: CA
Zip: 95070
Country: US
DeNovo Ventures was formed in 2000 by seasoned investors and experienced medical device entrepreneurs who sought to share the lessons learned from a history of successful investing and building successful companies. They believed that their unique combination of skills and perspectives could help entrepreneurs to build companies which would have significant clinical impact and generate superior returns. Seven years later, this belief continues to hold true, demonstrated by investment success in selected medical device and biotechnology companies. With $650 million under management, De Novo has made more than 40 investments in medical devices and biotechnology across three funds. They invest in all stages of enterprise development and growth – from early stage to late stage. The unique background of leading companies as entrepreneurs and operating executives from start to exit enables us to advise entrepreneurs and management teams over the full life cycle of the company.
Contact Phone:
+16503291999
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2011 | Simpirica Spine | Series C | 22M |
6/2004 | Paracor Medical | Series C | 30.5M |
6/2007 | Paracor Medical | Series D | 44M |
8/2007 | EndoGastric Solutions | Series D | 30M |
6/2009 | Facet Solutions | Debt Financing | 4.1M |
6/2011 | Spinal Modulation | Series D | 0 |
5/2014 | EndoGastric Solutions | Series G | 0 |
1/2016 | Benvenue Medical | Equity | 23M |
7/2003 | Bacchus Vascular | Series D | 25M |
5/2009 | PhotoThera | Series D | 50M |
4/2006 | PhotoThera | Series C | 30.5M |
4/2017 | Avedro | Venture Round | 0 |
11/2008 | OncoMed Pharmaceuticals | Series B | 154M |
5/2007 | Talima Therapeutics | Series B | 19M |
4/2006 | SynergEyes | Series B | 0 |
5/2007 | TRIA Beauty | Series D | 0 |
5/2009 | iScience Interventional | Series F | 20.5M |
6/2012 | Astute Medical | Series C | 40.4M |
6/2008 | EBR Systems | Series C | 35M |
1/2006 | Spinal Kinetics | Series B | 36M |
3/2005 | iScience Surgical | Series C | 0 |
1/2003 | Lumend | Series D | 23.2M |
9/2009 | Spinal Kinetics | Debt Financing | 5.3M |
1/2002 | Renovis | Series B | 0 |
12/2005 | Facet Solutions | Series B | 16.5M |
5/2005 | Bayhill Therapeutics | Series B | 35.4M |
1/2008 | Avedro | Series A | 8M |
2/2011 | Spiracur | Series C | 35M |
4/2012 | WaveTec Vision | Venture Round | 0 |
1/2008 | POINT Biomedical | Private Equity Round | 0 |
1/2012 | iScience Interventional | Venture Round | 2.8M |
5/2010 | TearScience | Series C | 44.5M |
2/2011 | TRIA Beauty | Venture Round | 26.3M |
10/2012 | TRIA Beauty | Venture Round | 7.5M |
7/2013 | TRIA Beauty | Private Equity Round | 0 |
4/2016 | TearScience | Series D | 0 |
8/2010 | EndoGastric Solutions | Series F | 0 |
6/2009 | EndoGastric Solutions | Venture Round | 3.8M |
6/2014 | Spinal Kinetics | Venture Round | 34M |
2/2009 | WaveTec Vision | Series C | 20.1M |
5/2011 | WaveTec Vision | Series D | 15.9M |
5/2007 | WaveTec Vision | Series B | 13M |
4/2011 | Benvenue Medical | Series C | 35.5M |
4/2006 | Bayhill Therapeutics | Venture Round | 15.8M |
5/2018 | Avedro | Series F | 0 |
1/2006 | Spinal Modulation | Series A | 7M |
3/2010 | Pulmonx | Series C | 0 |
6/2009 | Spiracur | Series B | 20.3M |
1/2012 | Pulmonx | Private Equity Round | 0 |
1/2007 | Ovalis | Series B | 0 |
1/2023 | Milo | Series A | 0 |
1/2007 | TearScience | Series B | 15.1M |
5/2005 | Talima Therapeutics | Series A | 1.6M |
1/2008 | Benvenue Medical | Series B | 15M |
4/2012 | EndoGastric Solutions | Venture Round | 0 |
5/2008 | Astute Medical | Series A | 6.3M |
11/2009 | EndoGastric Solutions | Series E | 0 |
10/2009 | EndoGastric Solutions | Venture Round | 0 |
6/2012 | EndoGastric Solutions | Venture Round | 0 |
3/2013 | Avedro | Series D | 0 |
11/2009 | Spinal Modulation | Series C | 27.4M |
7/2006 | InSound Medical | Series E | 18.9M |
6/2012 | Benvenue Medical | Series D | 25M |
2/2008 | InSound Medical | Series E | 11M |
12/2007 | AxoGen | Post-IPO Equity | 12.1M |
6/2014 | Benvenue Medical | Series E | 40M |
4/2003 | iScience Interventional | Series C | 15M |
7/2007 | CardioMind | Series C | 11M |
3/2008 | CardioMind | Venture Round | 22M |
12/2009 | EBR Systems | Venture Round | 15M |
3/2004 | Spinal Kinetics | Series A | 10M |
10/2008 | InSound Medical | Series E | 13M |
10/2005 | EBR Systems | Series B | 21M |
2/2009 | SynergEyes | Series C | 0 |
3/2006 | Cartilix | Series B | 6.3M |
4/2010 | Articulinx Inc. | Series B | 10M |
10/2007 | Vitreoretinal Technologies | Series A | 12M |
11/2005 | FlowMedica | Series D | 0 |
11/2007 | Viracta Therapeutics | Series A | 20M |
4/2010 | Viracta Therapeutics | Series B | 12M |
7/2008 | Sierra Surgical | Series B | 14.5M |
3/2004 | InSound Medical | Series D | 17.2M |
3/2011 | Astute Medical | Series B | 13M |
8/2007 | Sierra Surgical | Series A | 7.1M |
11/2005 | Ovalis | Series A | 0 |
5/2007 | Pulmonx | Series B | 20M |
3/2012 | Viracta Therapeutics | Series B | 0 |
5/2010 | Astute Medical | Series B | 26.5M |
6/2004 | EBR Systems | Series A | 5.2M |
2/2011 | EBR Systems | Series D | 5M |
8/2001 | MicroVention Terumo | Series C | 12.5M |
3/2003 | iScience Surgical | Series B | 0 |
10/2005 | PhotoThera | Series B | 19M |
9/2013 | MyoScience | Series E | 0 |
3/2012 | MyoScience | Series D | 0 |
7/2008 | MyoScience | Series B | 0 |
5/2018 | Avedro | Series F | 0 |
4/2017 | Avedro | Venture Round | 0 |
4/2016 | TearScience | Series D | 0 |
1/2016 | Benvenue Medical | Series F | 0 |
6/2014 | Benvenue Medical | Series E | 0 |
6/2014 | Spinal Kinetics | Venture Round | 0 |
5/2014 | EndoGastric Solutions | Series G | 0 |
9/2013 | MyoScience | Series E | 0 |
7/2013 | TRIA Beauty | Private Equity Round | 0 |
3/2013 | Avedro | Series D | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|